FDA Inspection
Biomat USA IncBiomat USA Inc – FDA Inspection, Apr 14, 2026
Record Details
This FDA Inspection record concerns Biomat USA Inc, with an inspection on April 14, 2026, issued by the Dallas District Office, covering biologics.
View Company Profile
ID · 443d0135-e7a6-42e7-818d-cda593ea65e0
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1312336
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
4- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
- 21 CFR 606.100(c)Thorough investigations
- 21 CFR 606.160(b)Required records
- 21 CFR 630.10(b)Form and manner of educational material
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Biomat USA Inc
1| Date | Classification | Office | Project area |
|---|---|---|---|
| August 23, 2018 | Not classified | Dallas District Office |
Other documents for Biomat USA Inc
- FDA Inspection 1068403 - 2018-08-23
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.